Bruton's tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing Multiple sclerosis: a randomised, placebo-controlled, phase 2 study
EUROPEAN JOURNAL OF NEUROLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
EUROPEAN JOURNAL OF NEUROLOGY(2019)